Your browser doesn't support javascript.
loading
Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable Immunodeficiency.
Fliegauf, Manfred; Bryant, Vanessa L; Frede, Natalie; Slade, Charlotte; Woon, See-Tarn; Lehnert, Klaus; Winzer, Sandra; Bulashevska, Alla; Scerri, Thomas; Leung, Euphemia; Jordan, Anthony; Keller, Baerbel; de Vries, Esther; Cao, Hongzhi; Yang, Fang; Schäffer, Alejandro A; Warnatz, Klaus; Browett, Peter; Douglass, Jo; Ameratunga, Rohan V; van der Meer, Jos W M; Grimbacher, Bodo.
Afiliación
  • Fliegauf M; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg 79108, Germany.
  • Bryant VL; Division of Immunology, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia.
  • Frede N; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg 79108, Germany.
  • Slade C; Division of Immunology, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia; Department of Clinical Immunology and Allergy, Royal Melbourne Hospital, Parkville, VIC 3050, Austr
  • Woon ST; Department of Virology and Immunology, Auckland City Hospital, Auckland 1023, New Zealand.
  • Lehnert K; School of Biological Sciences, University of Auckland, Auckland 1142, New Zealand.
  • Winzer S; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg 79108, Germany.
  • Bulashevska A; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg 79108, Germany.
  • Scerri T; Division of Immunology, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC 3010, Australia.
  • Leung E; Auckland Cancer Society Research Centre and Molecular Medicine and Pathology Department, University of Auckland, Auckland 1142, New Zealand.
  • Jordan A; Department of Clinical Immunology, Auckland City Hospital, Auckland 1023, New Zealand.
  • Keller B; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg 79108, Germany.
  • de Vries E; Department of Pediatrics, Jeroen Bosch Hospital, 's-Hertogenbosch 5200 ME, the Netherlands.
  • Cao H; BGI-Shenzhen, Shenzhen, 518083, China.
  • Yang F; BGI-Shenzhen, Shenzhen, 518083, China.
  • Schäffer AA; NCBI, NIH, Department of Health and Human Services, Bethesda, MD 20894, USA.
  • Warnatz K; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg 79108, Germany.
  • Browett P; Auckland Cancer Society Research Centre and Molecular Medicine and Pathology Department, University of Auckland, Auckland 1142, New Zealand.
  • Douglass J; Division of Immunology, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Clinical Immunology and Allergy, Royal Melbourne Hospital, Parkville, VIC 3050, Australia; Department of Medicine, The University of Melbourne, Parkville, VIC 3010, Australia.
  • Ameratunga RV; Department of Virology and Immunology, Auckland City Hospital, Auckland 1023, New Zealand.
  • van der Meer JW; Department of Internal Medicine, Radboud University Medical Centre, Nijmegen 6525 HP, the Netherlands.
  • Grimbacher B; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg 79108, Germany; Institute of Immunity and Transplantation, University College London, London WC1E 6BT, UK. Electronic address: bodo.grimbacher@uniklinik-freiburg.de.
Am J Hum Genet ; 97(3): 389-403, 2015 Sep 03.
Article en En | MEDLINE | ID: mdl-26279205
ABSTRACT
Common variable immunodeficiency (CVID), characterized by recurrent infections, is the most prevalent symptomatic antibody deficiency. In ∼90% of CVID-affected individuals, no genetic cause of the disease has been identified. In a Dutch-Australian CVID-affected family, we identified a NFKB1 heterozygous splice-donor-site mutation (c.730+4A>G), causing in-frame skipping of exon 8. NFKB1 encodes the transcription-factor precursor p105, which is processed to p50 (canonical NF-κB pathway). The altered protein bearing an internal deletion (p.Asp191_Lys244delinsGlu; p105ΔEx8) is degraded, but is not processed to p50ΔEx8. Altered NF-κB1 proteins were also undetectable in a German CVID-affected family with a heterozygous in-frame exon 9 skipping mutation (c.835+2T>G) and in a CVID-affected family from New Zealand with a heterozygous frameshift mutation (c.465dupA) in exon 7. Given that residual p105 and p50­translated from the non-mutated alleles­were normal, and altered p50 proteins were absent, we conclude that the CVID phenotype in these families is caused by NF-κB1 p50 haploinsufficiency.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunodeficiencia Variable Común / Subunidad p50 de NF-kappa B / Haploinsuficiencia Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans País/Región como asunto: Europa / Oceania Idioma: En Revista: Am J Hum Genet Año: 2015 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunodeficiencia Variable Común / Subunidad p50 de NF-kappa B / Haploinsuficiencia Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans País/Región como asunto: Europa / Oceania Idioma: En Revista: Am J Hum Genet Año: 2015 Tipo del documento: Article País de afiliación: Alemania